SPY384.24+0.35 0.09%
DIA311.87+0.10 0.03%
IXIC13,530.92+73.67 0.55%

Morgan Stanley Initiates Coverage On Axsome Therapeutics with Overweight Rating, Announces Price Target of $102

Morgan Stanley analyst Vikram Purohit initiates coverage on Axsome Therapeutics (NASDAQ:AXSM) with a Overweight rating and announces Price Target of $102.

· 09/10/2020 06:55
Morgan Stanley analyst Vikram Purohit initiates coverage on Axsome Therapeutics (NASDAQ:AXSM) with a Overweight rating and announces Price Target of $102.